New Provisional Classification of Juvenile Idiopathic Arthritis Applying Rheumatoid Factor and Antinuclear Antibody = New Provisional Classification of Juvenile Idiopathic Arthritis Applying Rheumatoid Factor and Antinuclear Antibody

다국어 초록 (Multilingual Abstract)

Objective. Previous classification systems for juvenile idiopathic arthritis (JIA) were based on the number of joints involved and did not categorize homogenous disease entities. Therefore, JIA patients were reclassified retrospectively by applying rheumatoid factor (RF) and antinuclear antibody (ANA), which have been proven to constitute a homogenous disease entity. Methods. The medical records of JIA patients were investigated retrospectively and reclassified into six categories using the new provisional classification. The nomenclature was based on Dr. Martini’s proposal in the 23rd European Paediatric Rheumatology Congress (2016) at Genoa, Italy. New categories included systemic JIA (sJIA), RF-positive JIA (RF-JIA), early-onset ANA-positive JIA (eoANA-JIA), enthesitis/spondylitis-related JIA (ESR-JIA), “other JIA”, and “unclassified JIA”. Results. Of a total of 262 JIA patients, 71 (27.1%) were reclassified as sJIA, 31 (11.8%) as RF-JIA, 22 (8.4%) as eoANA-JIA, 63 (24.0%) as ESR-JIA, 65 (24.8%) as “other JIA”, and 10 (3.8%) as “unclassified JIA”. A comparison of RF-JIA, eoANA-JIA, and ESR-JIA revealed significant differences in the gender ratio, age of disease onset, and the cumulative number and type of joints involved among the three groups. “Other JIA” comprised a significant proportion (24.8%) and warrants the need for further classification. The characteristics of the RF-positive patients were comparable to those of the anti-cyclic citrullinated peptide antibody-positive patients. The ANA positivity was lower (28.2%) than that in Western studies but showed similar clinical features. Conclusion. This is the first study applying RF and ANA to classify JIA without considering the joint counts. The six new categories include sJIA, RF-JIA, eoANA-JIA, ESR-JIA, “other JIA,” and “unclassified JIA”. (J Rheum Dis 2018;25:34-46)

참고문헌 (Reference)

1 이주훈, "연소성 류마티스 관절염의 임상적 고찰" 대한소아과학회 49 (49): 424-430, 2006

2 강민, "소아기류마티스관절염에서 항Cyclic Citrullinated Peptide항체의 임상적 유용성" 대한류마티스학회 21 (21): 236-240, 2014

3 Kroot EJ, "The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis" 43 : 1831-1835, 2000

4 Burgos-Vargas R, "The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist" 10 : 14-, 2012

5 Nielen MM, "Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors" 50 : 380-386, 2004

6 Petty RE, "Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997" 25 : 1991-1994, 1998

7 Guzman J, "Reliability of the articular examination in children with juvenile rheumatoid arthritis: interobserver agreement and sources of disagreement" 22 : 2331-2336, 1995

8 Fink CW, "Proposal for the development of classification criteria for idiopathic arthritides of childhood" 22 : 1566-1569, 1995

9 Shin JI, "Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria" 37 : 348-351, 2008

10 Tsitsami E, "Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis" 49 : 488-493, 2003

11 Stoll ML, "Patients with juvenile psoriatic arthritis comprise two distinct populations" 54 : 3564-3572, 2006

12 Ravelli A, "Patients with antinuclear antibody- positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease" 52 : 826-832, 2005

13 Borchers AT, "Juvenile idiopathic arthritis" 5 : 279-298, 2006

14 Prakken B, "Juvenile idiopathic arthritis" 377 : 2138-2149, 2011

15 Ravelli A, "Juvenile idiopathic arthritis" 369 : 767-778, 2007

16 Hofer MF, "Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria" 28 : 1083-1090, 2001

17 Arguedas O, "Juvenile chronic arthritis in urban San Jose, Costa Rica: a 2 year prospective study" 25 : 1844-1850, 1998

18 Aggarwal A, "Juvenile chronic arthritis in India: is it different from that seen in Western countries?" 14 : 53-56, 1994

19 Helliwell PS, "Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model" 43 : 865-871, 2000

20 Martini A, "It is time to rethink juvenile idiopathic arthritis classification and nomenclature" 71 : 1437-1439, 2012

21 Petty RE, "International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001" 31 : 390-392, 2004

22 Petty RE, "Growing pains: the ILAR classification of juvenile idiopathic arthritis" 28 : 927-928, 2001

23 Griffin TA, "Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets" 60 : 2113-2123, 2009

24 Saurenmann RK, "Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor" 56 : 1974-1984, 2007

25 Bracaglia C, "Elevated circulating levels of interferon-${\gamma}$ and interferon-${\gamma}$-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis" 76 : 166-172, 2017

26 Brewer EJ Jr, "Current proposed revision of JRA Criteria. JRA Criteria subcommittee of the diagnostic and therapeutic criteria committee of the American rheumatism section of the arthritis foundation" 20 (20): 195-199, 1977

27 "Criteria for the classification of juvenile rheumatoid arthritis" 23 : 712-719, 1972

28 Magni-Manzoni S, "Comparison of clinical versus ultrasound- determined synovitis in juvenile idiopathic arthritis" 61 : 1497-1504, 2009

29 Stoll ML, "Comparison of Vancouver and international league of associations for rheumatology classification criteria for juvenile psoriatic arthritis" 59 : 51-58, 2008

30 Colbert RA, "Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond" 6 : 477-485, 2010

31 European League Against Rheumatism, "Bulletin No. 4: Nomenclature and classification of arthritis in children" 1977

32 Barnes MG, "Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis" 62 : 3249-3258, 2010

33 Barnes MG, "B-cell signature in patients with JIA is associated with age of onset suggesting biologically relevant classification criteria" 60 (60): 620-, 2009

34 Martini A, "Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis?" 30 : 1900-1903, 2003

35 Ravelli A, "Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis" 63 : 267-275, 2011

36 Ferucci ED, "Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis" 52 : 239-246, 2005

37 Rantapaa-Dahlqvist S, "Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis" 48 : 2741-2749, 2003

38 Omar A, "Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial)" 80 : 38-43, 2013

39 van Rossum M, "Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis" 30 : 825-828, 2003

40 Aletaha D, "2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative" 62 : 2569-2581, 2010